Twist Bioscience (TWST) Change in Receivables (2017 - 2026)

Twist Bioscience (TWST) has 10 years of Change in Receivables data on file, last reported at $14.2 million in Q1 2026.

• Change in Receivables for Q1 2026 came in at $14.2 million, up 32.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.5 million (up 2.24% YoY), and the FY2025 annual result was $22.4 million, up 365.06% from the prior year.
• Change in Receivables advanced to $14.2 million in Q1 2026 per TWST's latest filing, from -$6.8 million in the prior quarter.
• Over five years, Change in Receivables peaked at $14.2 million in Q1 2026 and troughed at -$8.1 million in Q4 2023.
• A 5-year average of $2.0 million and a median of $1.8 million in 2022 frame the typical range for Change in Receivables.
• The sharpest annual moves came in 2022 and 2025: Change in Receivables slumped 328.28% in 2022, then jumped 1531.96% in 2025.
• A 5-year view of Change in Receivables shows it stood at $4.1 million in 2022, then tumbled by 296.63% to -$8.1 million in 2023, then jumped by 156.3% to $4.5 million in 2024, then sank by 250.45% to -$6.8 million in 2025, then soared by 308.58% to $14.2 million in 2026.
• Business Quant data shows TWST's Change in Receivables at $14.2 million in Q1 2026, -$6.8 million in Q4 2025, and $7.2 million in Q3 2025.